Pura Vida Investments, LLC Exelixis, Inc. Call Options Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $2.17 Million - $2.74 Million	-110,700 Closed	0 $0
Q4 2018 Feb 11, 2021	BUY	$13.65 - $21.8 $1.5 Million - $2.39 Million	109,593 Added 9900.0%	110,700 $2.18 Million
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $1.35 Million - $2.16 Million	-98,893 Reduced 98.89%	1,107 $55,000
Q3 2018 Feb 11, 2021	BUY	$15.87 - $22.4 $1.57 Million - $2.22 Million	99,000 Added 9900.0%	100,000 $1.77 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $787,152 - $1.11 Million	-49,600 Reduced 98.02%	1,000 $38,000
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $1.18 Million - $1.48 Million	50,600	50,600 $6.16 Million

460

240M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.35B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.